Published on 30 May 2016
Thank you to reviewers 2015
2.423 views
Published on 30 May 2016
2.423 views
Published on 30 May 2016
2.483 views
Published on 30 May 2016
2.536 views
Published on 30 May 2016
2.569 views
Published on 04 May 2016
Author(s): Alfredo García Arieta, PhD, Henrike Potthast, PhD, Hubert Leufkens, PhD, Jan Welink, John Gordon, PhD, Luther Gwaza, BPharm, MPhil, Marc Maliepaard, PhD, Matthias Stahl, MD
adjusted indirect comparisons, bioequivalence, drug switching, generic medicines, interchangeability, prequalification
DOI: 10.5639/gabij.2016.0502.015
12.515 views
Published on 04 May 2016
Author(s): Professor Philip D Walson, MD
DOI: 10.5639/gabij.2016.0501.001
3.176 views
Published on 27 April 2016
Author(s): Alejandra Babini, Associate Professor Valderilio Feijó Azevedo, MD, PhD, MSc, Igor Age Kos, Pablo Matar, PhD, Professor Fabio V Teixeira, MSc, MD, PhD
biosimilarity, extrapolation, infliximab, interchangeability, monoclonal antibodies, rituximab
DOI: 10.5639/gabij.2016.0502.017
12.347 views
Published on 18 April 2016
Author(s): Professor Philip D Walson, MD
chart review, consent, retrospective, waiver
DOI: 10.5639/gabij.2016.0501.004
16.155 views
Published on 18 April 2016
Author(s): GaBI Journal Editor
DOI: 10.5639/gabij.2016.0501.012
4.972 views
Published on 07 April 2016
Author(s): Falk Ehmann, MD, PhD, MSc, Ruben Pita, PharmD, LLM
complex pharmaceutical forms, EMA, nanomedicines, regulatory science
DOI: 10.5639/gabij.2016.0501.008
14.894 views
Published on 07 April 2016
Author(s): Professor Gerrit Borchard, PharmD, PhD
drug quality, ICH, non-biological complex drug (NBCD), Ph. Eur., pharmacopoeia, USP
DOI: 10.5639/gabij.2016.0501.009
18.126 views
Published on 07 April 2016
Author(s): Joshua D Brown, PharmD, MS
generic medicines, low-cost generic drug programs, quality assessment, United States healthcare system
DOI: 10.5639/gabij.2016.0501.003
4.768 views